Literature DB >> 17718665

Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.

Marie-Pascale Pomey1, Pierre-Gerlier Forest, Howard A Palley, Elisabeth Martin.   

Abstract

In January 1997, the government of Quebec, Canada, implemented a public/private prescription drug program that covered the entire population of the province. Under this program, the public sector collaborates with private insurers to protect all Quebecers from the high cost of drugs. This article outlines the principal features and history of the Quebec plan and draws parallels between the factors that led to its emergence and those that led to the passage of the Medicare Prescription Drug, Improvement and Modernization Act (MMA) in the United States. It also discusses the challenges and similarities of both programs and analyzes Quebec's ten years of experience to identify adjustments that may help U.S. policymakers optimize the MMA.

Mesh:

Year:  2007        PMID: 17718665      PMCID: PMC2690320          DOI: 10.1111/j.1468-0009.2007.00496.x

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  15 in total

1.  Outcomes-based drug coverage in British Columbia.

Authors:  Steven Morgan; Ken Bassett; Barbara Mintzes
Journal:  Health Aff (Millwood)       Date:  2004 May-Jun       Impact factor: 6.301

2.  US Medicare reform: why drug companies and private insurers are smiling.

Authors:  Jeremiah Hurley; Steven Morgan
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

Review 3.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

4.  Health care reform: why? What? When?

Authors:  Victor R Fuchs; Ezekiel J Emanuel
Journal:  Health Aff (Millwood)       Date:  2005 Nov-Dec       Impact factor: 6.301

Review 5.  The role of PBMs in implementing the Medicare prescription drug benefit.

Authors:  Robert F Atlas
Journal:  Health Aff (Millwood)       Date:  2004 Jul-Dec       Impact factor: 6.301

6.  The politics of health reform: why do bad things happen to good plans?

Authors:  Jonathan Oberlander
Journal:  Health Aff (Millwood)       Date:  2003 Jul-Dec       Impact factor: 6.301

7.  Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit.

Authors:  Bruce Stuart; Becky A Briesacher; Dennis G Shea; Barbara Cooper; Fatima S Baysac; M Rhona Limcangco
Journal:  Health Aff (Millwood)       Date:  2005 Jul-Aug       Impact factor: 6.301

8.  Can limiting choice increase social welfare? The elderly and health insurance.

Authors:  Yaniv Hanoch; Thomas Rice
Journal:  Milbank Q       Date:  2006       Impact factor: 4.911

9.  Tracking health care costs: trends slow in first half of 2003.

Authors:  Bradley C Strunk; Paul B Ginsburg
Journal:  Data Bull (Cent Stud Health Syst Change)       Date:  2003-12

10.  Potentially inappropriate prescriptions for older patients in long-term care.

Authors:  Carol Rancourt; Jocelyne Moisan; Lucie Baillargeon; René Verreault; Danielle Laurin; Jean-Pierre Grégoire
Journal:  BMC Geriatr       Date:  2004-10-15       Impact factor: 3.921

View more
  12 in total

1.  Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study.

Authors:  S P Krotneva; K E Reidel; A Verma; N Mayo; R Tamblyn; A N Meguerditchian
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

2.  Canadian pharmacare: looking back, looking forward.

Authors:  Steven G Morgan; Jamie R Daw
Journal:  Healthc Policy       Date:  2012-08

3.  Product listing agreements (PLAs): a new tool for reaching Quebec's pharmaceutical policy objectives?

Authors:  Mélanie Bourassa Forcier; François Noël
Journal:  Healthc Policy       Date:  2013-08

4.  Do stimulant medications improve educational and behavioral outcomes for children with ADHD?

Authors:  Janet Currie; Mark Stabile; Lauren Jones
Journal:  J Health Econ       Date:  2014-05-16       Impact factor: 3.883

5.  Medication access via hospital admission.

Authors:  Annie Wang; Trudo Lemmens; Navindra Persaud
Journal:  Can Fam Physician       Date:  2017-05       Impact factor: 3.275

6.  Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study.

Authors:  Christina J Qian; Janie Coulombe; Samy Suissa; Pierre Ernst
Journal:  Br J Clin Pharmacol       Date:  2017-05-07       Impact factor: 4.335

Review 7.  Evaluating the effects of Quebec's private-public drug insurance system.

Authors:  Steven G Morgan; Marc-André Gagnon; Mathieu Charbonneau; Alain Vadeboncoeur
Journal:  CMAJ       Date:  2017-10-10       Impact factor: 8.262

8.  Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs.

Authors:  David J T Campbell; Braden J Manns; Lesley J J Soril; Fiona Clement
Journal:  CMAJ Open       Date:  2017-11-22

9.  Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.

Authors:  Jenna Wong; Aude Motulsky; Michal Abrahamowicz; Tewodros Eguale; David L Buckeridge; Robyn Tamblyn
Journal:  BMJ       Date:  2017-02-21

Review 10.  Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.

Authors:  Jaden Brandt; Brenna Shearer; Steven G Morgan
Journal:  J Pharm Policy Pract       Date:  2018-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.